Frequency of returning to work one and six months following percutaneous coronary intervention for acute myocardial

Amr E Abbas1, Bruce Brodie, Gregg Stone

  • 1William Beaumont Hospital, Royal Oak, Michigan 48073, USA.

Insights

Most patients return to work after acute myocardial infarction treated with percutaneous coronary intervention. Predictors for early return include US employment, no smoking history, and single-vessel disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Acute myocardial infarction (AMI) significantly impacts patients' lives, including their ability to return to work.
  • Percutaneous coronary intervention (PCI) is a common treatment for AMI, but its effect on return-to-work timelines is crucial for patient recovery and economic well-being.

Purpose of the Study:

  • To determine the frequency of early (≤1 month) and late (≤6 months) return to work after PCI for AMI.
  • To identify variables associated with early and late return to work in patients post-PCI for AMI.

Main Methods:

  • Analysis of patients randomized in the Stent Primary Angioplasty in Myocardial Infarction trial.
  • Multivariate analysis to identify predictors of return to work at 1 month and 6 months post-PCI.
  • Comparison of event rates between patients who returned to work and those who did not.

Main Results:

  • 51% of employed patients returned to work within 1 month after PCI for AMI.
  • Predictors for early return included US employment, no smoking history, and single-vessel coronary disease.
  • By 6 months, 78% of patients had returned to work, with US employment and absence of angina being significant predictors.

Conclusions:

  • A majority of patients return to work within 6 months following PCI for AMI.
  • Factors such as employment location, smoking status, coronary artery disease extent, and angina presence influence return-to-work timelines.
  • Early return to work was not associated with increased adverse event rates.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...